ClinicalTrials.gg
Drug

Orphenadrine clinical trials

Also written Norflex.

studies test it
9
open now
2
in phase 3
2
first study started
2010

How each study uses Orphenadrine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Orphenadrine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 May 1957 · DISIPAL · NDA 010653 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Orphenadrine
6

Brand

Norflex
3

Studies by the year they started

9 studies that test it; most in 2015 (2)

Studies that test Orphenadrine, by start year
YearStudies
20101
20152
20161
20171
20201
20212
20251

By phase

A phase 1/2 study counts in both.

Phase 3
2
Phase 4
5
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 1 · Other 8

University of Puerto Rico (1) · Montefiore Medical Center (1) · AdventHealth (1) · University of Baghdad (1) · Sherief Abd-Elsalam (1) · Mansoura University (1) · Ache Laboratorios Farmaceuticos S.A. (1) · University of Illinois College of Medicine at Peoria (1)

Often tested with

Tested in the same studies.

Acetaminophen (4) · Ketorolac (2) · Gabapentin (2) · Bupivacaine (2) · Lidocaine (2) · Tramadol (2) · Ketorolac Tromethamine (1) · Epinephrine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Orphenadrine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 9

Codes

What other systems call Orphenadrine · ClinicalTrials.gg INT007931

  • MeSH (NLM) D009966OrphenadrineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) AL805O9OG9ORPHENADRINEConfirmed FDA, NLM, Wikidata
  • RxNorm 7715Confirmed FDA, Wikidata
  • Wikidata Q3292273orphenadrineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61868OrphenadrineOne source FDA
  • DrugBank DB01173One source Wikidata

Also registered as orphenadrine citrate (UNII X0A40N8I4S · RxNorm 7716) and orphenadrine hydrochloride (UNII UBY910DUXH · RxNorm 202723).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.